Auckland pharma company signs deal with US distributor © Getty AFT now expects earnings of between $9m and $11m.
Auckland-based drug maker AFT Pharmaceuticals had signed a licence and distribution agreement with a large US pharmaceutical distributor for the commercialisation of its Maxigesic pain killer.
Hikma Pharmaceuticals, the third biggest distributor in the US, will have exclusive rights to sell and distribute the intravenous, opioid-free post-operative pain relief medicine, in the United States.
It is AFT s first licensing agreement for the Maxigesic products in the US market. AFT is still waiting for approval for the tablet and liquid forms of the medication.
Auckland pharma company signs deal with US distributor
rnz.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rnz.co.nz Daily Mail and Mail on Sunday newspapers.
Sharemarket falls as investors quick to punish earnings downgrade
stuff.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stuff.co.nz Daily Mail and Mail on Sunday newspapers.
AFT Pharmaceuticals trims earnings forecast
rnz.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rnz.co.nz Daily Mail and Mail on Sunday newspapers.
AFT pharmaceuticals lowers earnings guidance, citing licensing delays
nbr.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbr.co.nz Daily Mail and Mail on Sunday newspapers.